Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer

NCT02016287 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Cancer
Elderly Patients

Interventions

OTHER: Sequential chemotherapy （paclitaxel 80mg/m2 d1,d8) and radiotherapy

Sponsor

Shen Lin